FDA moving closer to approving contrast for sonographic studies

This week we moved a major step closer to utilizing contrast in routine sonographic imaging:

http://www.businesswire.com/news/home/20111027006987/en/ICUS-Applauds-FDA-Modification-Boxed-Warnings-Ultrasound

ICUS Applauds FDA Modification of Boxed Warnings on Certain Ultrasound Contrast Agents; Cite Patient

www.businesswire.com

ICUS Applauds FDA decision to modify DEFINITY product labels. The FDA's decision should lead to better imaging studies, better diagnosis for patients